MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for ...
A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 9:00 ...
The "Nebulizer Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering. The Global Nebulizer Market is expected to reach US$ 2 ...
Just when you think you’ve gotten over that respiratory infection, bronchitis hits. The coughing, chest soreness, and fatigue can really get you down. While acute bronchitis will usually go away ...
Which portable nebulizer is best? For anyone who has chronic issues with breathing, a nebulizer can be a game-changer. It lets you live a whole, rich life you may not have believed possible. That’s ...
Self treatment of the respiratory tract using inhalation nebulizer. For a patient at high risk of severe Covid-19 related complications, newly released data shows that inhaled remdesivir offers the ...
- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.
LAKE FOREST, Ill. -- An ongoing shortage of a medicine commonly used to treat people with breathing problems is expected to get worse after a major supplier to US hospitals shut down last week, CNN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback